XML 22 R29.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Quarterly Financial Data (Unaudited)
 12 Months Ended
Dec. 31, 2019
Quarterly Financial Data [Abstract]  
Quarterly Financial Data (Unaudited) Quarterly Financial Data (Unaudited)
 
2019 Quarters
(in millions, except per share data)
1st

 
2nd

 
3rd

 
4th

Net revenues
$
5,628

 
$
6,619

 
$
6,856

 
$
6,007

Gross profit
$
2,811

 
$
3,319

 
$
3,497

 
$
3,084

Net earnings (losses)
$
1,121

 
$
1,997

 
$
(2,602
)
 
$
(1,814
)
Net earnings (losses) attributable to Altria
$
1,120

 
$
1,996

 
$
(2,600
)
 
$
(1,809
)
Per share data:

 

 

 

Basic earnings (losses) per share attributable to Altria
$
0.60

 
$
1.07

 
$
(1.39
)
 
$
(0.97
)
Diluted earnings (losses) per share attributable to Altria
$
0.60

 
$
1.07

 
$
(1.39
)
 
$
(1.00
)
 
 
 
 
 
 
 
 
 
2018 Quarters
(in millions, except per share data)
1st

 
2nd

 
3rd

 
4th 

Net revenues
$
6,108

 
$
6,305

 
$
6,837

 
$
6,114

Gross profit
$
2,936

 
$
3,141

 
$
3,255

 
$
2,922

Net earnings (losses)
$
1,895

 
$
1,877

 
$
1,944

 
$
1,251

Net earnings (losses) attributable to Altria
$
1,894

 
$
1,876

 
$
1,943

 
$
1,250

Per share data:

 

 

 

Basic earnings (losses) per share attributable to Altria
$
1.00

 
$
0.99

 
$
1.03

 
$
0.67

Diluted earnings (losses) per share attributable to Altria
$
1.00

 
$
0.99

 
$
1.03

 
$
0.66



During 2019 and 2018, the following pre-tax (gains) or charges were included in net earnings attributable to Altria:
 
2019 Quarters
(in millions)
1st

 
2nd

 
3rd

 
4th

Impairment of JUUL equity securities
$
—

 
$
—

 
$
4,500

 
$
4,100

Tobacco and health litigation items, including accrued interest
17

 
28

 
3

 
29

Asset impairment, exit, implementation and acquisition-related costs
159

 
45

 
11

 
116

ABI-related special items
114

 
(90
)
 
(14
)
 
(364
)
Cronos-related special items
425

 
119

 
549

 
(165
)
 
$
715

 
$
102

 
$
5,049


$
3,716

 
 
 
 
 
 
 
 
 
2018 Quarters
(in millions)
1st

 
2nd

 
3rd

 
4th 

NPM Adjustment Items
$
(68
)
 
$
(77
)
 
$
—

 
$
—

Tobacco and health litigation items, including accrued interest
28

 
70

 
21

 
12

Asset impairment, exit, implementation and acquisition-related costs
3

 
6

 
(3
)
 
532

(Gain) loss on ABI/SABMiller business combination
33

 
—

 
—

 
—

ABI-related special items
(117
)
 
(72
)
 
35

 
69

 
$
(121
)
 
$
(73
)
 
$
53

 
$
613


As discussed in Note 15. Income Taxes, Altria has recognized income tax benefits and charges in the consolidated statements of earnings (losses) during 2019 and 2018 as a result of various tax events, including the impact of the Tax Reform Act in 2018.